On November 4th, 2026, BIO-RED held its first Cross-Regional Showcase, “Ideas Without Borders”, an online event bringing together innovators, investors, and ecosystem stakeholders from across Europe to explore how cross-regional collaboration can turn ideas into opportunities. As a BIO-RED partner, AccelBio supported the event alongside the other partners from the project’s seven regions.

The showcase was organised together with BIO-RED’s sister project, HELIX, a health data ecosystem. After a welcome from BIO-RED Project Manager Beatriz Pereira, the programme presented BIO-RED and the opportunities it offers to participating teams, followed by an introduction to the HELIX platform, its collaboration opportunities, and its upcoming funding call, presented by HELIX Project Manager Anabela Veiga.

The “Hackathon Stories” session gave the floor to innovators who took part in the BIO-RED inter-regional hackathons. Rui Carvalho Santos from Portugal, Saulius Fomenko from Lithuania, and Krasimira Rusinova-Ilieva from Bulgaria shared how they found new teammates, tested their solutions in new ecosystems, and turned a local idea into a cross-regional story. The session was moderated by Kristina Eskenazi (HLSC, Bulgaria) and Simona Šimulytė (LithuaniaBio).

The event closed with the Solution Testing & Readiness Firetalk, an open conversation with international investors on what it takes to move a therapeutic, diagnostic, or advanced therapy from the lab to proof of concept: generating robust preclinical and clinical evidence, navigating regulatory pathways, and building the data package that convinces life-science investors to commit. The speakers were Christian Kumar of Med Tech Makers Lab (UK) and Dr. Georgios Varsos of VU Venture Partners (USA), and the session was moderated by Stamatiki Kritas of the Hellenic Biocluster (HBio).

The showcase reflected the idea behind the whole BIO-RED journey: hack locally, grow across Europe. You can find out more about the project and its Open Innovation Platform at bio-red.eu.

AccelBio took part in the Innovating Health Together Conference 2026 (IHTC’26), “Resilient and Sustainable Health Systems for the Future”, a two-day event held on October 27th and 28th, 2026, in Lisbon at Iscte – Instituto Universitário de Lisboa. Our Senior Translational Researcher, João Travassos Leandro, and our CSO, Sílvia Almeida, represented the team at the conference.

The conference focused on how health systems can remain resilient, sustainable, and responsive in the face of demographic, technological, economic, and environmental pressures. It brought together policymakers, health leaders, industry, startups, researchers, and investors to discuss topics such as resilient health systems and policy, sustainable models of care, data, digital and AI, personalised health and prevention, and global collaboration.

Building resilient health systems also means turning scientific discoveries into tomorrow’s therapies. At AccelBio, we work to bridge biomedical research and drug discovery, accelerating innovation through collaboration, and events like this one are a valuable opportunity to connect, exchange perspectives, and explore ways to bring science closer to patients.

On October 26th, 2026, the BIO-RED Inter-Regional Final Pitch Session brought together the 14 regional finalists from across all the BIO-RED Cross-Regional Hackathons, who presented their business cases to an international jury with members from the seven BIO-RED regions. Ten of them have now been selected for the BIO-RED Biotech & Pharma Accelerator Programme.

We are particularly proud that one of the selected teams, OrganoSynch, includes our PhD student Mafalda Vicente, who took part in the hackathon in Ioannina, Greece, alongside colleagues from across Europe. Congratulations to Mafalda and to the whole team!

The ten selected business cases are TwinOrg, CMC Master, RegBridge, Municipal Health Data & AI Gateway, RESP O₂, ScaleEU, OrganoSynch, RareBridge, ATMP Bridge™, and Transla EU. Congratulations to all of them, and thank you to every team that presented at the final pitch session.

The programme will be delivered in two parts. The first focuses on business case development, with three online workshops on value proposition and team, commercial strategy and market access, and regulatory pathway and IP strategy, held between November 17th and December 2nd. Each team will also benefit from 15 hours of personalised mentoring from a lead mentor and specialised experts. The second part prepares teams for fundraising and investment readiness, through two additional workshops, two online sessions, and a Final Showcase Event in Portugal in the second half of 2027. Overall, the programme represents €9,000 worth of support per business case, helping teams strengthen their business cases, prepare to raise public and private funding from mid-2027 onwards, and connect with relevant experts, partners, and investors across the BIO-RED ecosystem.

As a BIO-RED partner, AccelBio helped organise the Portuguese hackathon at Biocant Park in September and took part in the Greek hackathon in October, so it is a pleasure to see the project’s hackathons lead to concrete next steps for so many teams.

On October 15th and 16th, 2026, the Hellenic Biocluster (HBio) hosted the BIO-RED Cross-Regional Hackathon “Organoids & Drug Discovery: From Lab Models to Patient Decisions” in Ioannina, Greece. Run in a hybrid format, it was HBio’s very first hackathon, and AccelBio took part online with two members of our team.

Interregional teams from Greece, Bulgaria, Romania, Portugal, the Netherlands, France, and the USA worked together over two days to develop solutions to three challenges facing the sector today: standardising organoid models so that systems are reproducible and comparable across labs, smart organoid manufacturing and analytics to scale production and turn data into reliable insight, and precision medicine, bringing patient-derived models closer to clinical decisions. The hackathon also brought together local research, industry, and innovation stakeholders, who shared breakthroughs and good practices and offered insights on entrepreneurship.

We are proud of our team’s contribution. Our PhD student Mafalda Vicente joined one of the interregional teams, participating online alongside colleagues from across Europe, and her team secured 2nd place. Congratulations, Mafalda! Our Innovation Manager, João Maia, also attended online and was one of the jury members, bringing his expertise in innovation and entrepreneurship.

The competition continues: the winning teams from all the Cross-Regional Hackathons will compete in the BIO-RED Inter-Regional Final Pitch Session on October 26th for a place in the BIO-RED Biotech & Pharma Accelerator Programme. Good luck to all the finalists!

Our thanks go to HBio for hosting the event, and to all the participants, speakers, mentors, and jury members who made it so memorable.

AccelBio’s CEO, Bárbara Gomes, attended the workshop “Knowledge Valorisation in Action: from Results to Policy” on October 8th, 2026, at the Centre Albert Borschette in Brussels. The event was organised by the European Research Executive Agency (REA), in cooperation with the European Commission’s Directorate-General for Research and Innovation, and brought together a cluster of Horizon Europe projects that piloted new approaches to knowledge valorisation.

The day opened with remarks from Martin Špolc, Director for Prosperity at DG Research and Innovation, and Stephen Collins, Director of REA. It continued with testimonials from project partners on how valorisation methodologies changed their business plans, partnerships, and relationships with citizens, before moving on to sessions on bringing research results to society and bringing research results to the market. Speakers presented lessons from projects such as CO-VALUE, BEAGLE, KALEIDOS, and VOICE, covering topics from citizen engagement and living labs to industry-academia collaboration and user-driven innovation in healthcare. The afternoon was dedicated to a plenary discussion on carrying these learnings forward, followed by a wrap-up from Iphigenia Pottaki of DG Research and Innovation.

Knowledge valorisation is at the heart of AccelBio’s work. As a collaborative laboratory bridging academia and industry, we are committed to translating scientific discoveries into real-world impact, and we coordinate TransBioNet, a European project building the first pan-European network of knowledge valorisation intermediaries dedicated to drug discovery. Events like this are a valuable opportunity to learn from other projects, connect with the wider European valorisation community, and keep our work aligned with the policy conversation

From September 30th to October 2nd, 2026, the neuromuscular disease research community gathered aboard the SS Rotterdam for the iPSC Modeling in Neuromuscular Disorders Meeting (iMND meeting 2026), three days of sharing and discussing the latest advances in the field. Our Principal Scientist in Advanced In Vitro Systems, Afonso Malheiro, took part in the meeting and was one of the selected speakers.

Scientists from around the world presented innovative strategies to model neuromuscular disorders, with a particular focus on the use of induced pluripotent stem cells (iPSCs) to study diseases such as amyotrophic lateral sclerosis/frontotemporal dementia (ALS/FTD) and spinal muscular atrophy (SMA).

On the first day, September 30th, Afonso spoke in the afternoon session “Therapeutics and Toxicology”, where he presented AccelBio’s latest advances in developing a human-based platform for modelling sporadic ALS, with the ultimate goal of enabling drug screening and accelerating the discovery of new therapeutic strategies.

The meeting was a great opportunity to exchange ideas, connect with fellow researchers, and contribute to the ongoing efforts to advance neuromuscular disease research. We are already looking forward to the next meeting, in Aachen in 2028.

Contact Us

geral@accelbio.pt+351 918 439 722
Call to national mobile network
Laboratório Colaborativo AccelBio
Biocant Park,
Parque Tecnológico de Cantanhede,
3060-197 Cantanhede
2026 Co-Lab AccelBio All rights reserved ©
|
Designed and built by BOTODACRUZ